| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands
|
ten Berge, Deirdre M.H.J.
|
|
|
165 |
C |
p. 195-204
|
artikel
|
| 2 |
Dramatic response to brigatinib in a lung adenocarcinoma patient harboring EML4-ALK fusion and a G1202R de novo gene mutation
|
Pan, Yue
|
|
|
165 |
C |
p. 154-156
|
artikel
|
| 3 |
Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancer
|
Antoniotti, Carlotta
|
|
|
165 |
C |
p. 116-124
|
artikel
|
| 4 |
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel – results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO
|
Lorenzen, Sylvie
|
|
|
165 |
C |
p. 48-57
|
artikel
|
| 5 |
Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in Japan
|
Horita, Nobuyuki
|
|
|
165 |
C |
p. 113-115
|
artikel
|
| 6 |
Inhibition of renalase drives tumour rejection by promoting T cell activation
|
Guo, Xiaojia
|
|
|
165 |
C |
p. 81-96
|
artikel
|
| 7 |
Letter comments on anti-PD(L)1 immunotherapies in patients with cancer and with pre-existing systemic sclerosis: a post-marketed safety assessment study
|
Ikeda, Satoshi
|
|
|
165 |
C |
p. 205-207
|
artikel
|
| 8 |
Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort
|
Wang, Yuehan
|
|
|
165 |
C |
p. 27-47
|
artikel
|
| 9 |
Market access to new anticancer medicines for children and adolescents with cancer in Europe
|
Schoot, Reineke A.
|
|
|
165 |
C |
p. 146-153
|
artikel
|
| 10 |
Morusin enhances the antitumor activity of MAPK pathway inhibitors in BRAF-mutant melanoma by inhibiting the feedback activation of STAT3
|
Zhao, Kun
|
|
|
165 |
C |
p. 58-70
|
artikel
|
| 11 |
Omicron variant: A clear and present danger for patients with cancer
|
Barrière, J.
|
|
|
165 |
C |
p. 25-26
|
artikel
|
| 12 |
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study
|
Ladoire, Sylvain
|
|
|
165 |
C |
p. 13-24
|
artikel
|
| 13 |
Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial
|
Liu, Zhenzhen
|
|
|
165 |
C |
p. 157-168
|
artikel
|
| 14 |
Persisting cancer mortality gap between western and eastern Europe
|
Santucci, Claudia
|
|
|
165 |
C |
p. 1-12
|
artikel
|
| 15 |
Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
|
Kennedy, Oliver J.
|
|
|
165 |
C |
p. 97-112
|
artikel
|
| 16 |
Quality of life and quality of care as experienced by patients with advanced cancer and their relatives: A multicentre observational cohort study (eQuiPe)
|
van Roij, Janneke
|
|
|
165 |
C |
p. 125-135
|
artikel
|
| 17 |
Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!
|
Di Noia, Vincenzo
|
|
|
165 |
C |
p. 169-173
|
artikel
|
| 18 |
Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study
|
Verso, Melina
|
|
|
165 |
C |
p. 136-145
|
artikel
|
| 19 |
Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
|
Heudel, Pierre
|
|
|
165 |
C |
p. 174-183
|
artikel
|
| 20 |
The letter responds to comment on: Anti-PD(L)1 immunotherapies in patients with cancer and with pre-existing systemic sclerosis: a post-marketed safety assessment study
|
Panhaleux, Marion
|
|
|
165 |
C |
p. 208-209
|
artikel
|
| 21 |
The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC
|
Acem, Ibtissam
|
|
|
165 |
C |
p. 71-80
|
artikel
|
| 22 |
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
|
Mair, Maximilian J.
|
|
|
165 |
C |
p. 184-194
|
artikel
|
Tijdschrift beschrijving